Form 4: PTC Therapeutics Executive VP Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Lee Scott Golden, EVP & Chief Medical Officer of PTC Therapeutics, sold shares of common stock to cover tax withholding obligations related to vesting Restricted Stock Units (RSUs).
Summary
- Lee Scott Golden, an Executive Vice President and Chief Medical Officer at PTC Therapeutics, sold shares of the company's common stock on January 7th and 8th, 2025.
- The sales were executed to cover tax withholding obligations associated with the vesting of Restricted Stock Units (RSUs).
- On January 7th, 810 shares were sold at a price of $45.34 per share.
- On January 8th, 1,198 shares were sold at a price of $44.50 per share.
- Following these transactions, Golden directly owns 78,651 shares of PTC Therapeutics common stock.
Sentiment
Score: 5
Explanation: This is a routine transaction related to tax obligations, so it's neutral in sentiment.
Industry Context
Executive stock sales for tax purposes are a common occurrence, especially around RSU vesting events. It doesn't necessarily indicate a negative outlook on the company.
Key Dates
| Date | Description |
|---|---|
| January 6, 2021 | Grant of 3,960 RSUs |
| January 7, 2022 | Grants totaling 14,155 RSUs |
| January 5, 2023 | Grant of 10,640 RSUs |
| January 7, 2025 | Sale of 810 shares at $45.34 |
| January 8, 2025 | Sale of 1,198 shares at $44.50 |
| January 10, 2025 | Date of Form 4 signature |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.